Richard Vosser
Stock Analyst at JP Morgan
(1.44)
# 2,939
Out of 5,182 analysts
17
Total ratings
55.56%
Success rate
-0.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Richard Vosser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVO Novo Nordisk | Downgrades: Neutral | n/a | $44.87 | - | 8 | Feb 24, 2026 | |
| MOLN Molecular Partners AG | Maintains: Neutral | $4 → $3.75 | $4.25 | -11.76% | 3 | Dec 8, 2025 | |
| GRFS Grifols | Maintains: Neutral | $10 | $8.27 | +20.92% | 1 | Dec 8, 2025 | |
| SNY Sanofi | Downgrades: Neutral | n/a | $43.36 | - | 4 | Dec 8, 2025 | |
| NVS Novartis AG | Upgrades: Overweight | n/a | $145.50 | - | 1 | Dec 8, 2025 |
Novo Nordisk
Feb 24, 2026
Downgrades: Neutral
Price Target: n/a
Current: $44.87
Upside: -
Molecular Partners AG
Dec 8, 2025
Maintains: Neutral
Price Target: $4 → $3.75
Current: $4.25
Upside: -11.76%
Grifols
Dec 8, 2025
Maintains: Neutral
Price Target: $10
Current: $8.27
Upside: +20.92%
Sanofi
Dec 8, 2025
Downgrades: Neutral
Price Target: n/a
Current: $43.36
Upside: -
Novartis AG
Dec 8, 2025
Upgrades: Overweight
Price Target: n/a
Current: $145.50
Upside: -